Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Monday 12 February, 2018

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 6113E
GlaxoSmithKline PLC
12 February 2018
 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr R G Connor

b)

Position/status

President, Global Manufacturing & Supply

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

 

b)

Nature of the transaction

The exercise of options over 2,250 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£11.47

2,250

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

 

 

e)

Date of the transaction

2018-02-12

f)

Place of the transaction

 

n/a

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr R G Connor

b)

Position/status

President, Global Manufacturing & Supply

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

 

 

 

 

 

 

b)

Nature of the transaction

The sale of 2,250 Ordinary Shares following the exercise of options granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£12.9258

2,250

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

 

 

e)

Date of the transaction

2018-02-12

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLLFFVLFZBBX

a d v e r t i s e m e n t